13F
中

INDV INDIVIOR PHARMACEUTICALS INC

2026Q1 · CUSIP 45579U109 · Sector: Healthcare & Biotech

Lit · Institutions accelerating in
Holders
285
Δ holders QoQ
+273
Breadth percentile
Top 0%
Whale holders
138
Δ whales
+137
Inst. holding value
$3.7B
New positions
276
Closed positions
3
Price momentum (1Q)
—
Put / Call
3/4

Breadth history (34 quarters)

2025Q4: Δ+11 · h=12 2026Q1: Δ+273 · h=285 2025Q4: holders=12 2026Q1: holders=285 -273 -136.5 +0 +136.5 +273 10155300 25Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 1 lit events

Period Percentile Next-1Q return Next-2Q return
2026Q1 Top 0% — —

Options Sentiment

Put holders
3
QoQ: +3
Call holders
4
QoQ: +4

See methodology →

Fundamentals

PE (TTM)
20.8
EPS (TTM)
$1.95
EPS YoY
—
Revenue (TTM)
$1.3B
Revenue YoY
+10.3%
Quarterly Revenue & EPS (4Y)
2024-03-31: $284M 2024-06-30: $299M 2024-09-30: $307M 2024-12-31: $298M 2025-03-31: $266M 2025-06-30: $302M 2025-09-30: $314M 2025-12-31: $357M 2026-03-31: $317M 2024-03-31: EPS 0.45 2024-06-30: EPS -0.72 2024-09-30: EPS 0.16 2024-12-31: EPS 0.16 2025-03-31: EPS 0.38 2025-06-30: EPS 0.14 2025-09-30: EPS 0.33 2025-12-31: EPS 0.79 2026-03-31: EPS 0.69 0M 179M 357M $M -0.79 0.04 0.87 202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 28 2024-12-31: PE 196.62025-06-30: PE 27.92025-09-30: PE 30.22025-12-31: PE 21.12026-03-31: PE 18.9 17 112 206 202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)